-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Caribou Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
- Caribou Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$38.2M, a 161% decline year-over-year.
- Caribou Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$165M, a 51.3% decline year-over-year.
- Caribou Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$116M, a 9.08% decline from 2022.
- Caribou Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$106M, a 58.9% decline from 2021.
- Caribou Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$67M, a 85.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)